Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pancreatic Neoplasms × Blood Specimen Collection × Clear all

Phase

Status

Sponsor Class

OTHER 32 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 9 Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 6 Breast Neoplasms 6 Prostatic Neoplasms 5 Papillomavirus Infections 5 Ovarian Neoplasms 4 Neoplastic Cells, Circulating 4 Uterine Cervical Neoplasms 3 Uterine Cervical Dysplasia 3 Lung Neoplasms 3 Melanoma 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Carcinoma, Hepatocellular 2 Thymic aplasia 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Respiratory Distress Syndrome 1 Recurrence 1 Rectal Neoplasms 1 Radiation Injuries 1 Pulmonary Disease, Chronic Obstructive 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Opioid-Related Disorders 1

Interventions

Gemcitabine 202 130-nm albumin-bound paclitaxel 81 Albumin-Bound Paclitaxel 56 pembrolizumab 43 Fluorouracil 40 Leucovorin 33 Oxaliplatin 32 Capecitabine 25 Nivolumab 21 Irinotecan 18 Bevacizumab 17 Paclitaxel 16 Cetuximab 15 Cyclophosphamide 14 Taxes 13 Erlotinib Hydrochloride 13 Drug Therapy 13 Carboplatin 12 irinotecan sucrosofate 11 Injections 10 Cisplatin 9 ALT-803 8 spartalizumab 7 olaparib 7 fludarabine 7 avelumab 7 Pemetrexed 7 Docetaxel 7 ruxolitinib 6 TH 302 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05191940 2026-03-20

LAPC

EBG MedAustron GmbH

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡